267 related articles for article (PubMed ID: 31348240)
1. Risk factors for drug-resistant epilepsy: A systematic review and meta-analysis.
Xue-Ping W; Hai-Jiao W; Li-Na Z; Xu D; Ling L
Medicine (Baltimore); 2019 Jul; 98(30):e16402. PubMed ID: 31348240
[TBL] [Abstract][Full Text] [Related]
2. Incidence and Prevalence of Drug-Resistant Epilepsy: A Systematic Review and Meta-analysis.
Sultana B; Panzini MA; Veilleux Carpentier A; Comtois J; Rioux B; Gore G; Bauer PR; Kwon CS; Jetté N; Josephson CB; Keezer MR
Neurology; 2021 Apr; 96(17):805-817. PubMed ID: 33722992
[TBL] [Abstract][Full Text] [Related]
3. Predictive factors of drug-resistant epilepsy in children presenting under 2 years of age: experience of a tertiary center in Turkey.
Yildiz EP; Gunes D; Bektas G; Aksu Uzunhan T; Tatli B; Caliskan M; Aydinli N; Ozmen M
Acta Neurol Belg; 2018 Mar; 118(1):71-75. PubMed ID: 29063291
[TBL] [Abstract][Full Text] [Related]
4. The epidemiology of drug-resistant epilepsy: A systematic review and meta-analysis.
Kalilani L; Sun X; Pelgrims B; Noack-Rink M; Villanueva V
Epilepsia; 2018 Dec; 59(12):2179-2193. PubMed ID: 30426482
[TBL] [Abstract][Full Text] [Related]
5. Early versus late antiepileptic drug withdrawal for people with epilepsy in remission.
Strozzi I; Nolan SJ; Sperling MR; Wingerchuk DM; Sirven J
Cochrane Database Syst Rev; 2015 Feb; 2015(2):CD001902. PubMed ID: 25922863
[TBL] [Abstract][Full Text] [Related]
6. Predicting drug resistance in adult patients with generalized epilepsy: A case-control study.
Voll A; Hernández-Ronquillo L; Buckley S; Téllez-Zenteno JF
Epilepsy Behav; 2015 Dec; 53():126-30. PubMed ID: 26561950
[TBL] [Abstract][Full Text] [Related]
7. Drug-resistant idiopathic generalized epilepsy: A meta-analysis of prevalence and risk factors.
Jiang T; Zhang X; Zhang M; Liu M; Zhu H; Sun Y
Epilepsy Behav; 2023 Sep; 146():109364. PubMed ID: 37523796
[TBL] [Abstract][Full Text] [Related]
8. Drug resistant epilepsy and associated factors among children with epilepsies in tanzania: a cross-sectional study.
Urio OH; Kija E; Weckhuysen S; Makungu H; Naburi H
BMC Neurol; 2024 Jan; 24(1):8. PubMed ID: 38166885
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for Drug-resistant Epilepsy (DRE) and a nomogram model to predict DRE development in post-traumatic epilepsy patients.
Yu T; Liu X; Sun L; Lv R; Wu J; Wang Q
CNS Neurosci Ther; 2022 Oct; 28(10):1557-1567. PubMed ID: 35822252
[TBL] [Abstract][Full Text] [Related]
10. Genetic factors and the risk of drug-resistant epilepsy in young children with epilepsy and neurodevelopment disability: A prospective study and updated meta-analysis.
Lin CH; Chou IC; Hong SY
Medicine (Baltimore); 2021 Mar; 100(12):e25277. PubMed ID: 33761731
[TBL] [Abstract][Full Text] [Related]
11. Clinical features and drug-resistance in pediatric epilepsy with co-occurring autism: A retrospective comparative cohort study.
Lob K; Hou T; Chu TC; Ibrahim N; Bartolini L; Nie DA
Epilepsy Behav; 2023 Jun; 143():109228. PubMed ID: 37182499
[TBL] [Abstract][Full Text] [Related]
12. Carbamazepine versus phenytoin monotherapy for epilepsy: an individual participant data review.
Nevitt SJ; Marson AG; Weston J; Tudur Smith C
Cochrane Database Syst Rev; 2017 Feb; 2(2):CD001911. PubMed ID: 28240353
[TBL] [Abstract][Full Text] [Related]
13. Lacosamide add-on therapy for focal epilepsy.
Babar RK; Bresnahan R; Gillespie CS; Michael BD
Cochrane Database Syst Rev; 2021 May; 5(5):CD008841. PubMed ID: 33998660
[TBL] [Abstract][Full Text] [Related]
14. Carbamazepine versus phenobarbitone monotherapy for epilepsy: an individual participant data review.
Nolan SJ; Marson AG; Weston J; Tudur Smith C
Cochrane Database Syst Rev; 2016 Dec; 12(12):CD001904. PubMed ID: 27976799
[TBL] [Abstract][Full Text] [Related]
15. Carbamazepine versus phenobarbitone monotherapy for epilepsy: an individual participant data review.
Nolan SJ; Marson AG; Weston J; Tudur Smith C
Cochrane Database Syst Rev; 2015 Jul; (7):CD001904. PubMed ID: 26204241
[TBL] [Abstract][Full Text] [Related]
16. Prevalence, risk factors, and prognosis of drug-resistant epilepsy in autoimmune encephalitis.
Wesselingh R; Broadley J; Buzzard K; Tarlinton D; Seneviratne U; Kyndt C; Stankovich J; Sanfilippo P; Nesbitt C; D'Souza W; Macdonell R; Butzkueven H; O'Brien TJ; Monif M
Epilepsy Behav; 2022 Jul; 132():108729. PubMed ID: 35623203
[TBL] [Abstract][Full Text] [Related]
17. Preoperative evaluation and surgical management of infants and toddlers with drug-resistant epilepsy.
Pindrik J; Hoang N; Smith L; Halverson M; Wojnaroski M; McNally K; Gedela S; Ostendorf AP
Neurosurg Focus; 2018 Sep; 45(3):E3. PubMed ID: 30173613
[TBL] [Abstract][Full Text] [Related]
18. Postencephalitic epilepsy and drug-resistant epilepsy after infectious and antibody-associated encephalitis in childhood: Clinical and etiologic risk factors.
Pillai SC; Mohammad SS; Hacohen Y; Tantsis E; Prelog K; Barnes EH; Gill D; Lim MJ; Brilot F; Vincent A; Dale RC
Epilepsia; 2016 Jan; 57(1):e7-e11. PubMed ID: 26592968
[TBL] [Abstract][Full Text] [Related]
19. Vigabatrin add-on therapy for drug-resistant focal epilepsy.
Bresnahan R; Gianatsi M; Maguire MJ; Tudur Smith C; Marson AG
Cochrane Database Syst Rev; 2020 Jul; 7(7):CD007302. PubMed ID: 32730657
[TBL] [Abstract][Full Text] [Related]
20. Multivariable prediction model of drug resistance in adult patients with generalized epilepsy from Colombia: A case-control study.
Orozco-Hernández JP; Quintero-Moreno JF; Marín-Medina DS; Valencia-Vásquez A; Villada HC; Lizcano A; Martínez JW
Epilepsy Behav; 2018 Nov; 88():176-180. PubMed ID: 30290326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
